Live Breaking News & Updates on Multi Platform Comparison
Stay updated with breaking news from Multi platform comparison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
General Atomics: Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for its SARS-CoV-2 neutralizing antibody test. The Diazyme test is a high throughput chemiluminescent immunoassay with excellent correlation to a fluorescence based neutralization assay, which has been used to evaluate the adaptive immune response in vaccine studies 1. Diazyme also announced plans to work with US FDA for EUA application. Unlike the widely available total SARS-CoV-2 IgG antibody tests, Diazyme s neutralizing antibody test measures the subset of neutralizing antibodies that block the interaction between the receptor binding domain (RBD) of the viral spike glycoprotein and the human ACE2 cell surface receptor. The Diazyme neutralizing antibody test gives the scientific community and health authorities a v ....